Even folks who aren't into football tune into the Super Bowl for its ads, but this year there's some "big drama" around one ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Moreover, the stigma surrounding obesity disproportionately affects lower-income individuals, who are often blamed for their ...